Scientific Program

Dr. Ekaparna Hazarika

Poster Title: Metaplastic Carcinoma of Breast – An Old Histotype with New Diagnostic Challenges: Experience Of an Oncology Referral Centre
Affiliation: MD in Pathology- Gauhati Medical College and Hospital Hospital, Assam, India
 
Biography: Dr. Ekaparna Hazarika has completed her MBBS in the year 2017, following which she pursued her MD in Pathology in Gauhati Medical College and Hospital, Assam, India, in the year 2023. She is currently pursuing her Fellowship in Oncopathology at State Cancer Institute, Assam, India. Her areas of interest are Oncopathology, Head and Neck oncology, Breast pathology and Lymphoma.

Dr. Madina Jakhongirova

Speech Title: Molecular and Clinicopathologic Analysis of Undifferentiated Carcinoma with Osteoclast-Like Giant Cells of the Pancreas: A Case Report Series.
Affiliation : LLC Ipsum Pathology – Tashkent, Uzbekistan
 
Biography: Dr. Madina Jakhongirova is an accomplished pathologist and molecular diagnostics expert, serving as a leading consultant at LLC Ipsum Pathology—the first public-private partnership (PPP) laboratory in Uzbekistan and the country’s pioneer in providing advanced immunohistochemistry (IHC) and next-generation sequencing (NGS) services. With extensive expertise in oncopathology, she was selected to join the national focus group under WHO affiliation to develop evidence-based clinical guidelines for breast and cervical cancer. Her leadership and scientific contributions have played a central role in shaping precision oncology practices in the region. Dr. Jakhongirova completed specialized international training in India in hematologic malignancy diagnostics and continues to advocate for precision medicine by integrating histopathology with genomic technologies. She maintains active international collaborations with specialists from the United States, Russia, and other countries, further enhancing her expertise and contributing to global knowledge exchange in cancer diagnostics.

Mr. Omar Ali

Speech Title: Innovative Contracting with new medicines
Affiliation: Visiting Lecturer and Former Government Adviser To Nice Uk
 
Can we afford a Cure? Paying for innovation with new cancer medicines
With new innovative medicines comes ever increasing drug prices; we explore the challenges facing governments and healthcare institutions to providing timely access to life saving medicines.
 
The increasing creativity in negotiations between drug companies and governments are seeing a growth in innivative contractign and value based agreements; where, if the drug doesnt work – then we dont pay !
 
This presentation will showcase global trends and explore some amazing case studies whereby the unafordable has become affordable, allowing for patients to access multi-million dollar drugs.

Dr. Esraa Aldujaily

Speech Title: Macrophage Class Switching and Targeting of Tumour Immunology in Lung Cancer
Affiliation: Head of the Department of Pathology and Forensic Medicine at the University of Kufa/ Faculty of Medicine.
 
Biography: Dr. Esraa Aldujaily has completed her PhD from the United Kingdom University of Leicester . She is currently the head of the department of pathology and forensic medicine at the University of Kufa/ Faculty of Medicine. She has published more than 20 abstracts in different journals and conferences.
 

Dr. Ibrahim Mansoor

Speech Title: Digital Pathology 360°: Scanners, Standards, Software, and Strategy vs. PACS – Where Do We Stand?
Affiliation: Surgical and Clinical Pathologist, Director of Laboratory Services at Kings College London Jeddah
 
Biography: Dr. Ibrahim Mansoor is a Surgical and Clinical Pathologist, trained at Northwestern University Feinberg School of Medicine in Chicago, IL.  He also acquired fellowship training from Yale School of Medicine, New Haven CT and Mayo Clinic Rochester, MN. He practiced in the United Sates before deciding to come back to the Middle East and serve IMC as director of the Lab and blood bank and now Director of Laboratory services at Kings College London Jeddah. Dr. Mansoor has extensively published in various disciplines of pathology and has given multiple Grand Rounds and National Review courses in collaboration with Mayo Clinic in many renown institutions nationally in the USA as well as internationally.

Assist Prof. Nadia Hameed

Speech Title: Diagnostic Challenges of Emerging and Common High-Grade Endometrial Carcinoma Entities
Affliction: Assistant Professor, Department of Pathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center
 
Biography: Nadia Hameed has completed her MBChB degree from the University of Baghdad, College of Medicine.
Anatomic and Clinical Pathology Residency at the University of South Alabama. Surgical Oncology Pathology Fellowship and Gynecologic Pathology Fellowship at MD Anderson Cancer. I am a member of USCAP, ASCP, and CAP, and serve as a podcast moderator at ISGyP. I have published abstracts in gynecologic pathology, and the most recent one is about high-grade pilomatrix-like carcinoma of the endometrium.